- John Lee, 79, Elizabethtown, KY (1942-2022)
- Attleboro, Mansfield students top Bishop-Feehan senior class
- Robbie Williams’ wife Ayda Field shares a selfie from hospital as she undergoes a colonoscopy
- Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma
- Surging Chronic Diseases favorable to Global Drug Discovery Market Growth
- Surging Chronic Diseases favorable to Global Drug Discovery Market Growth
- Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma
- Ipsen: ASCO 2022: New Cabometyx® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer
- Lessons From the Syrian Crises for Cancer Care in Ukraine
- NEW DATA SHOWCASES HOW AMGEN IS ADVANCING ALL ANGLES OF CANCER CARE THROUGH INNOVATIVE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2022
- Surging Chronic Diseases favorable to Global Drug Discovery Market Growth
- EQRx Announces New Data for Lead Oncology Programs in Non-small Cell Lung Cancer and Rare Form of Non-Hodgkin Lymphoma at ASCO 2022
- 23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results
- CARVYKTI® (Ciltacabtagene Autoleucel) erhält von der Europäischen Kommission bedingte Zulassung für die Behandlung von Patienten mit rezidiviertem und refraktärem multiplem Myelom
- CARVYKTI® (Ciltacabtagene Autoleucel) erhält von der Europäischen Kommission bedingte Zulassung für die Behandlung von Patienten mit rezidiviertem und refraktärem multiplem Myelom
When you include the American Institute for Cancer Research in your estate plans, you make a major difference in the fight against cancer.
Corporate Champions who partner with the American Institute for Cancer Research stand at the forefront of the fight against cancer
The AICR Lifestyle & Cancer Symposium addresses the most current and consequential issues regarding diet, obesity, physical activity and cancer.
The Annual AICR Research Conference is the most authoritative source for information on diet, obesity, physical activity and cancer.
The Continuous Update Project (CUP) is an ongoing program that analyzes global research on how diet, nutrition and physical activity affect cancer risk and survival.
A major milestone in cancer research, the Third Expert Report analyzes and synthesizes the evidence gathered in CUP reports and serves as a vital resource for anyone interested in preventing cancer.
Whether you are a healthcare provider, a researcher, or just someone who wants to learn more about cancer prevention, we’re here to help.
Read real-life accounts of how AICR is changing lives through cancer prevention and survivorship.
We bring a detailed policy framework to our advocacy efforts, and provide lawmakers with the scientific evidence they need to achieve our objectives.
AICR champions research that increases understanding of the relationship between nutrition, lifestyle, and cancer.
Are you ready to make a difference? Join our team and help us advance research, improve cancer education and provide lifesaving resources.
AICR’s resources can help you navigate questions about nutrition and lifestyle, and empower you to advocate for your health.
AICR is committed to putting what we know about cancer prevention into action. To help you live healthier, we’ve taken the latest research and made 10 Cancer Prevention Recommendations.
